- Influences of Patient Activation on Diabetes Self-Care Activities and Diabetes-Specific Distress
-
Choi S, Kim SH
- KMID: 2471025
- Korean J Adult Nurs.
- 2020 Feb;32(1):10-20.
- doi: 10.7475/kjan.2020.32.1.10
PURPOSE: The purpose of the study was to evaluate the influence of patient activation on diabetes self-care activities and diabetes-specific distress among patients with type 2 diabetes mellitus. METHODS: This cross-sectional... -
- CITED
-
- Close
- SHARE
-
- Close
- Response: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)
-
Chung YR, Ha KH, Lee K, Kim DJ
- KMID: 2466516
- Diabetes Metab J.
- 2019 Dec;43(6):917-918.
- doi: 10.4093/dmj.2019.0216
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Letter: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)
-
Moon JS
- KMID: 2466513
- Diabetes Metab J.
- 2019 Dec;43(6):911-912.
- doi: 10.4093/dmj.2019.0207
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome
-
Seo JB, Choi YK, Woo HI, Jung YA, Lee S, Lee S, Park M, Lee IK, Jung GS, Park KG
- KMID: 2466504
- Diabetes Metab J.
- 2019 Dec;43(6):830-839.
- doi: 10.4093/dmj.2018.0181
BACKGROUND: The hypoglycemic drugs dipeptidyl peptidase-4 (DPP-4) inhibitors have proven protective effects on diabetic kidney disease, including renal fibrosis. Although NOD-like receptor protein 3 (NLRP3) inflammasome activation is known to... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of evogliptin and cenicriviroc against nonalcoholic steatohepatitis in mice: a comparative study
-
Wang Z, Park H, Bae EJ
- KMID: 2461038
- Korean J Physiol Pharmacol.
- 2019 Nov;23(6):459-466.
- doi: 10.4196/kjpp.2019.23.6.459
Dipeptidyl peptidase (DPP)-4 inhibitors, or gliptins, are a class of oral hypoglycemic drugs that have been widely used as a second-line treatment for type 2 diabetes. Gliptins, which were introduced... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-diabetic effects of blue honeyberry on high-fed-diet-induced type II diabetic mouse
-
Sharma A, Kim JW, Ku SK, Choi JS, Lee HJ
- KMID: 2464115
- Nutr Res Pract.
- 2019 Oct;13(5):367-376.
- doi: 10.4162/nrp.2019.13.5.367
BACKGROUND/OBJECTIVE: The blue honeysuckle berry (Lonicera caerulea var. edulis L.) is a small deciduous shrub belonging to the Caprifoliaceae family that is native to Russia, China, Japan, and Korea. The... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Flaxseed Enriched Yogurt on the Glycemic Status and Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus: Randomized, Open-labeled, Controlled Study
-
Hasaniani , Rahimlou M, Ramezani Ahmadi A, Mehdizadeh Khalifani A, Alizadeh M
- KMID: 2461096
- Clin Nutr Res.
- 2019 Oct;8(4):284-295.
- doi: 10.7762/cnr.2019.8.4.284
Flaxseed is one of the rich sources of α-linolenic acid and lignan. Flaxseed and its components have antioxidant, hypolipidemic and hypoglycemic effects. The study aimed to investigate the effect of... -
- CITED
-
- Close
- SHARE
-
- Close
- Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study
-
Chung YR, Ha KH, Kim HC, Park SJ, Lee K, Kim DJ
- KMID: 2460957
- Diabetes Metab J.
- 2019 Oct;43(5):640-648.
- doi: 10.4093/dmj.2018.0137
BACKGROUND: To investigate the effects of dipeptidyl peptidase-4 inhibitor (DPP4i) as add-on medications to metformin on progression of diabetic retinopathy (DR) in patients with type 2 diabetes mellitus, compared with... -
- CITED
-
- Close
- SHARE
-
- Close
- Cancer Risk in Patients with Type 2 Diabetes on Antidiabetic Monotherapy: A Population Based Cohort Study Using National Insurance Health Service Database
-
Jung HY, Lee S
- KMID: 2463633
- Korean J Clin Pharm.
- 2019 Sep;29(3):186-192.
- doi: 10.24304/kjcp.2019.29.3.186
BACKGROUND: Diabetes is associated with cancer risk in the aging population. Observational studies have indicated the beneficial effects of metformin against breast cancer, making studies on the anticancer potential of... -
- CITED
-
- Close
- SHARE
-
- Close
- Oral Hypoglycemic Agents for Patients with Type 2 Diabetes Mellitus
-
Ko SH
- KMID: 2458963
- J Korean Diabetes.
- 2019 Sep;20(3):142-148.
- doi: 10.4093/jkd.2019.20.3.142
For patients with newly diagnosed type 2 diabetes mellitus (T2DM), lifestyle modifications including medical nutrition therapy, weight control, physical activity, smoking cessation, and avoidance of alcohol abuse should be initiated.... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety Issues with Sodium-Glucose Cotransporter 2 Inhibitors: Clinical Considerations
-
Lim S
- KMID: 2458961
- J Korean Diabetes.
- 2019 Sep;20(3):127-135.
- doi: 10.4093/jkd.2019.20.3.127
Diabetes mellitus (DM) is linked to poor outcomes after cardiovascular events and renal complications. Recently, novel antidiabetic agents, such as dipeptidyl peptidase-4 inhibitors, sodium-glucose cotransporter 2 (SGLT2) inhibitors, and glucagon-like... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-limb Roux-en-Y Reconstruction after Subtotal Gastrectomy to Treat Severe Diabetic Gastroparesis
-
Park JM, Kim JW, Chi KC
- KMID: 2458835
- J Gastric Cancer.
- 2019 Sep;19(3):365-371.
- doi: 10.5230/jgc.2019.19.e23
The role of surgical intervention in patients with diabetic gastroparesis is unclear. We report a case of a 37-year-old man with a history of recurrent episodes of vomiting and long-standing... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea
-
Kang YM, Jung CH, Lee SH, Kim SW, Song KH, Kim SG, Kim JH, Cho YM, Park TS, Ku BJ, Koh G, Kim DM, Lee BW, Park JY
- KMID: 2455667
- Diabetes Metab J.
- 2019 Aug;43(4):432-446.
- doi: 10.4093/dmj.2018.0092
BACKGROUND: We aimed to investigate the effectiveness and safety of adding basal insulin to initiating dipeptidyl peptidase-4 (DPP-4) inhibitor and metformin and/or sulfonylurea (SU) in achieving the target glycosylated hemoglobin... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacotherapy of Diabetes Focused on Stroke
-
Lyu YS, Kim JH, Kim SY
- KMID: 2454786
- J Korean Neurol Assoc.
- 2019 Aug;37(3):235-250.
- doi: 10.17340/jkna.2019.3.1
Cardiovascular disease, including stroke, is one of the major causes of death in diabetes. Numerous studies have long suggested reducing macrovascular complication such as ischemic vascular disease through intensive glycemic... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Effect of Quadruple Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus Who Have Insulin Limitations
-
Yoo WS, Kim DH, Kim HJ, Chung HK
- KMID: 2451842
- J Korean Diabetes.
- 2019 Jun;20(2):117-126.
- doi: 10.4093/jkd.2019.20.2.117
BACKGROUND: Insulin therapy is the treatment of choice in type 2 diabetes mellitus (T2DM) patients who are not achieving glycemic goals despite triple oral hypoglycemic agent (OHA) combination therapy. However,... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevention of Major Adverse Cardiovascular and Renal Outcomes with Sodium-Glucose Cotransporter 2 Inhibitors
-
Hong JH
- KMID: 2451837
- J Korean Diabetes.
- 2019 Jun;20(2):87-91.
- doi: 10.4093/jkd.2019.20.2.87
Management of hyperglycemia limits progression of microvascular complications in type 2 diabetes mellitus (T2DM). According to large-scale randomized control studies to demonstrate the cardiovascular safety of sodium-glucose cotransporter 2 (SGLT2)... -
- CITED
-
- Close
- SHARE
-
- Close
- The Role of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Reducing Cardiovascular Events in Patients with Type 2 Diabetes
-
Kim GS, Park JH, Won JC
- KMID: 2450509
- Endocrinol Metab.
- 2019 Jun;34(2):106-116.
- doi: 10.3803/EnM.2019.34.2.106
The prevalence of type 2 diabetes mellitus (T2DM), which is associated with cardiovascular morbidity and mortality, is increasing worldwide. Although there have been advances in diabetes treatments that reduce microvascular... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors Influencing Glycemic Control among Type 2 Diabetes Mellitus Patients: The Sixth Korea National Health and Nutrition Examination Survey (2013~2015)
-
Gu MO
- KMID: 2450088
- Korean J Adult Nurs.
- 2019 Jun;31(3):235-248.
- doi: 10.7475/kjan.2019.31.3.235
PURPOSE: This study was conducted to examine factors influencing glycemic control among type 2 Diabetes Mellitus (T2DM) patients using data from the sixth Korea National Health and Nutrition Examination Survey... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke
-
Ahn CH, Lim S
- KMID: 2449891
- J Stroke.
- 2019 May;21(2):139-150.
- doi: 10.5853/jos.2019.00038
Patients with hyperglycemia are at a high risk of cardio- and cerebrovascular diseases. Diabetes patients also have poor outcomes after cerebrovascular disease development. Several classes of drugs are used for... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effects of Hypoglycemic Agents on Non-alcoholic Fatty Liver Disease: Focused on Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists
-
Jung CH, Mok JO
- KMID: 2452623
- J Obes Metab Syndr.
- 2019 Mar;28(1):18-29.
- doi: 10.7570/jomes.2019.28.1.18
The only known, effective intervention for non-alcoholic fatty liver disease (NAFLD) is weight loss, and there is no approved pharmacotherapy. Recently, new hypoglycemic agents, such as sodium-glucose cotransporter 2 (SGLT2)... -
- CITED
-
- Close
- SHARE
-
- Close
